Company intelligence / Profile preview

Nanosonic Products

Sydney, New South Wales, Australia

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Nanosonics is the global leader in automated high-level disinfection technologies for ultrasound probes and increasingly for flexible endoscope reprocessing, with trophon and Coris devices forming the backbone of their infection prevention clinical results, setting high standards in automated HLD efficacy and digital traceability[1][2][6][10].

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

GE Healthcare[11]McKesson[4]

Beyond the preview

Go deeper on Nanosonic Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanosonic Products.

Explore the full profile